Additionally it is accredited for Grownups who're overweight with one or more pounds-similar ailments, including higher hypertension or Form 2 diabetic issues (substantial blood sugar). In March of 2024, the FDA authorized an extra indicator for Wegovy—to decreased the chance of cardiovascular death, coronary heart attack, and stroke in adults https://glp-1weightlossmed.com/product/wegovy/